1-2 of 2
Evangelia Razis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study

Nicholas C. Turner, Judith Balmaña, Coralie Poncet, Theodora Goulioti, Konstantinos Tryfonidis, Aafke H. Honkoop, Gabriele Zoppoli, Evangelia Razis, Oskar T. Johannsson, Marco Colleoni, Andrew N. Tutt, William Audeh, Michail Ignatiadis, Audrey Mailliez, Olivier Trédan, Antonino Musolino, Peter Vuylsteke, Maria Jose Juan-Fita, Iain R.J. Macpherson, Bella Kaufman, Luis Manso, Lori J. Goldstein, Susan L. Ellard, István Láng, Kai Yu Jen, Virginie Adam, Saskia Litière, John Erban, David A. Cameron
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (20): 5482–5491.
https://doi.org/10.1158/1078-0432.CCR-21-0310
Published: 15 October 2021
View article titled, Niraparib for Advanced Breast Cancer with Germline <em>BRCA1</em> and <em>BRCA2</em> Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study
Open the PDF for Niraparib for Advanced Breast Cancer with Germline <em>BRCA1</em> and <em>BRCA2</em> Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment

Evangelia Razis, Panayotis Selviaridis, Stephanos Labropoulos, Jeremy L. Norris, Mei-Jun Zhu, David D. Song, Thea Kalebic, Michael Torrens, Anna Kalogera-Fountzila, George Karkavelas, Sofia Karanastasi, Jonathan A. Fletcher, George Fountzilas
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6258–6266.
https://doi.org/10.1158/1078-0432.CCR-08-1867
Published: 30 September 2009
View article titled, Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Open the PDF for Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment in another window